AXDX

Accelerate Diagnostics
AXDX

Overview Fund Activity
Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

66 hedge funds and large institutions have $17.2M invested in Accelerate Diagnostics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
13
Closed
16
Calls
$8K
Puts
$29K
Net Calls
-$21K
Net Calls Change
+$75K

Top Buyers

1
GAM
1
Griffin Asset Management
New York
$7.17M
2
AF
2
Allworth Financial
California
$108K
3
TC
3
Tejara Capital
United Kingdom
$254K
4
Northern Trust
4
Northern Trust
Illinois
$105K
5
UBS Group
5
UBS Group
Switzerland
$35.6K

Top Sellers

1
GCP
1
GSA Capital Partners
United Kingdom
$0
2
DKCM
2
Davidson Kempner Capital Management
New York
$0
3
Millennium Management
3
Millennium Management
New York
$418K
4
OIM
4
Oracle Investment Management
Connecticut
$1.06M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CCB
76
Cutter & Co Brokerage
Missouri
– -$9.64K -1,358 Closed
HF
77
HRT Financial
New York
– -$9K -1,293 Closed
Corient Private Wealth
78
Corient Private Wealth
Florida
– -$8.83K -1,250 Closed
Citadel Advisors
79
Citadel Advisors
Florida
– -$6.44K -912 Closed
IA
80
IFP Advisors
Florida
– -$1K -7 Closed
1 2 3
4